Analysts have great faith in incoming Ambu CEO

Britt Meelby Jensen, who was appointed the new chief executive of Ambu yesterday, is the obvious candidate to rebuild trust in the medtech firm after years of downgrades, say analysts.

Photo: PR / Ambu

Britt Meelby Jensen, who was appointed the next CEO of Ambu on Thursday, is the right person for the job of reestablishing faith in the medtech company, which has disappointed analysts with seven downgrades since 2019, say a number of analysts according to Danish media Finans.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs